Current treatment options for chronic granulomatous disease (Q34706880)

4 August 2017

1 reference

title

Current treatment options for chronic granulomatous disease (English)

1 reference

chronic granulomatous disease

4 August 2017

main subject

1 reference

David Goldblatt

1

1 reference

ORCID Public Data File 2021

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Expert Opinion on Pharmacotherapy

4 August 2017

published in

1 reference

4 August 2017

volume

3

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

857-863

1 reference

An Improved Nitroblue Tetrazolium Test Using Phorbol Myristate Acetate-coated Coverslips

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Burkholderia pseudomalleiInfection in a Puerto Rican Patient with Chronic Granulomatous Disease: Case Report and Review of Occurrences in the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Activity of antibiotics in chronic granulomatous disease leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Disseminated nocardiosis in a patient with X-linked chronic granulomatous disease and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Clinical perspectives of granulocyte transfusions: efficacy to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Colitis in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Gastrointestinal Complications of Chronic Granulomatous Disease: Case Report and Literature Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Aspergillus nidulans Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

Alloimmunization after granulocyte transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.857

21 January 2018

Identifiers

DOI

10.1517/14656566.3.7.857

1 reference

4 August 2017

1 reference